Key result
Pediatric thrombosis is rarely idiopathic, driven primarily by central catheters and underlying medical conditions.
Why the study?
Thrombotic risk factors and thrombosis in children have been receiving increased attention due to their heterogeneity and unique developmental hemostasis.
This review emphasizes the rarity of idiopathic thrombosis in children, the critical role of central catheters as a risk factor, and the importance of understanding developmental hemostasis in pediatric thrombosis management.
Heterogeneity in pediatric thrombosis complicates risk assessment; leaves open standardized evaluation protocols.
Thrombotic risk factors and thrombosis in children has been receiving increased attention. True idiopathic thrombosis is extremely rare in children. Most patients have a significant underlying medical condition and the presence of a central catheter is the most important risk factor. Children are more likely than adults to have one or more significant genetic abnormality or coagulation deficiency. This review discusses problems concerning the heterogeneity of thrombotic states in children and highlights the importance of understanding the concept of developmental hemostasis. Issues regarding step-wise test selection and the interpretation of results are addressed, as well as basic monitoring of anticoagulant drug effects.
No takes yet. Share an insight, caveat, or question.
Alenka Trampuš-Bakija (2010) conducted a review in Pediatric thrombosis. Pediatric thrombosis is rarely idiopathic and is most commonly associated with underlying medical conditions or the presence of a central catheter.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: